MLEC

BEARISH

$7.52 Live

Moolec Science SA · NASDAQ

$3.08 52W Range $157.05

MLEC Moolec Science SA - Fundamental Analysis

BEARISH

Console Chart News

MLEC Stock | Fundamental Analysis & Investment Insights

NASDAQ • Healthcare • Biotechnology

Current Price Live

$7.52

52W High

$157.05

52W Low

$3.08

Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 14, 2026

Market cap

$5.46M

P/E

N/A

ROE

N/A

Profit margin

N/A

Debt/Equity

N/A

Dividend yield

N/A

AI Analysis

AI-powered fundamental assessment

Confidence

95%

MLEC exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across nearly all health metrics. The company is currently pre-revenue with 0.00% margins and a catastrophic price trajectory, losing 93% of its value over the last year and 99.5% over five years. With no Graham Number or Intrinsic Value calculable due to the lack of earnings and revenue, the stock is trading as a highly speculative micro-cap with deteriorating momentum.

Key Strengths

Recent quarterly EPS surprises have been positive relative to low expectations

Operates in the high-innovation Biotechnology sector

Low absolute share price may attract high-risk speculative traders

Forward P/E suggests a defined (though negative) earnings expectation

Micro-cap size allows for extreme volatility on any positive clinical news

Key Risks

Extreme bankruptcy risk implied by a 1/9 Piotroski F-Score

Complete absence of revenue and profit margins

Severe capital erosion with a 5-year price decline of 99.5%

High Price-to-Book ratio (10.76) for a non-profitable entity

Negative YoY EPS growth of -100%

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Weak

Value

Future

Past

Health

Dividend

AI Verdict

High Risk / Speculative Avoid

Key drivers: Critical Piotroski F-Score, Zero revenue generation, Catastrophic historical price performance, Negative earnings growth

Confidence

90%

Value

10/100

P/E N/A, Forward P/E -31.33, Graham Number None

Positives

No standout positives identified.

Watchpoints

P/B ratio of 10.76 is excessive for a company with no earnings
No Graham Number available due to lack of EPS

Future

15/100

Ref Growth rates and EPS progression

Positives

Occasional EPS beats on very low estimates

Watchpoints

YoY EPS growth is -100%
No revenue growth data available

Past

0/100

Ref Historical price trends

Positives

No standout positives identified.

Watchpoints

1Y Change: -93.0%
5Y Change: -99.5%
Recent 1W Change: -34.3%

Health

11/100

Ref Piotroski F-Score

Positives

No standout positives identified.

Watchpoints

Piotroski F-Score of 1/9 is in the 'Weak' category
Lack of available Altman Z-Score suggests insufficient data or extreme distress

Dividend

0/100

Ref Yield, Payout

Positives

No standout positives identified.

Watchpoints

No dividend yield
0/100 Dividend Strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$7.52

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for MLEC and closest competitors.

Updated 2026-04-13

Company	5Y	3Y	1Y	6M	1M	1W
MLEC Moolec Science SA Primary	-99.5%	-98.7%	-93.0%	-33.2%	-26.5%	-34.3%
CLGN CollPlant Biotechnologies Ltd. Peer	-97.4%	-95.1%	-85.0%	-83.7%	-43.0%	-33.0%
INBS Intelligent Bio Solutions Inc. Peer	-100.0%	-99.3%	-79.8%	-77.0%	-39.7%	-10.6%
BIAF bioAffinity Technologies, Inc. Peer	-99.5%	-98.4%	-92.9%	-86.5%	+9.8%	-1.5%
JAGX Jaguar Health, Inc. Peer	-100.0%	-100.0%	-92.8%	-82.2%	-34.7%	-7.8%

MLE

Moolec Science SA

Primary

-99.5%

-98.7%

-93.0%

-33.2%

-26.5%

-34.3%

CLG

CollPlant Biotechnologies Ltd.

Peer

-97.4%

-95.1%

-85.0%

-83.7%

-43.0%

-33.0%

INB

Intelligent Bio Solutions Inc.

Peer

-100.0%

-99.3%

-79.8%

-77.0%

-39.7%

-10.6%

BIA

bioAffinity Technologies, Inc.

Peer

-99.5%

-98.4%

-92.9%

-86.5%

+9.8%

-1.5%

JAG

Jaguar Health, Inc.

Peer

-100.0%

-92.8%

-82.2%

-34.7%

-7.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

N/A

-31.33

N/A

10.76

N/A

$5.46M

Profitability

Profit margins and return metrics

Profit Margin N/A

Operating Margin N/A

Gross Margin N/A

ROE N/A

ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A

Earnings Growth N/A

Q/Q Revenue Growth N/A

Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

N/A

Current Ratio

N/A

Quick Ratio

N/A

Cash/Share

$N/A

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2024

Revenue

$0.0B

Gross Margin

-25.5%

Op. Margin

-77.9%

Net Margin

-91.8%

Total Assets

$0.0B

Liabilities

$0.0B

Equity

$0.0B

Debt/Equity

10.22x

Operating CF

$-0.0B

CapEx

$-0.0B

Free Cash Flow

$-0.0B

FCF Yield

134%

Quarterly Earnings History

EPS performance vs analyst estimates

2025-07-02

$N/A

2025-04-16

$-0.6

2025-01-31

$-0.5

+28.6% surprise

2024-10-30

$-0.6

Healthcare Sector Comparison

Comparing MLEC against 319 companies in the Healthcare sector (20 bullish, 107 neutral, 192 bearish)

Similar Companies

Peer comparison within the same industry

Company	AI Rating	Market Cap	P/E	ROE	Profit Margin	Price
MLEC Moolec Science SA	BEARISH	$5.46M	-	-%	-%	$7.52
CLGN CollPlant Biotechnologies Ltd.	BEARISH	$5.18M	-	-117.6%	-%	$0.36	Compare
INBS Intelligent Bio Solutions Inc.	BEARISH	$4.92M	-	-150.2%	-%	$2.46	Compare
BIAF bioAffinity Technologies, Inc.	BEARISH	$6.07M	-	-245.2%	-217.5%	$1.35	Compare
JAGX Jaguar Health, Inc.	BEARISH	$4.58M	-	-%	-%	$0.37	Compare

MLEC Moolec Science SA

BEARISH

Mkt Cap

$5M

P/E

ROE

Price

$7.52

Compare with MLEC

Compare with MLEC

Compare with MLEC

JAGX Jaguar Health, Inc.

Compare with MLEC

Past News Coverage

Recent headlines mentioning MLEC from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V2 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends

MLEC

MLEC Moolec Science SA - Fundamental Analysis

At a glance

AI Analysis

Key Strengths

Key Risks

Performance Snowflake

Stock Price & Analyst Targets

Multi-Horizon Performance vs Peers

Historical Performance Trends

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Valuation Metrics

Profitability

Growth

Financial Health

Financial Statement Flow

Quarterly Earnings History

Healthcare Sector Comparison

Similar Companies

Past News Coverage

Wait — Don't Miss Out!